SEC Form 4 · accession 0001144204-15-055334
TITAN PHARMACEUTICALS INC · TTNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sunil Bhonsle
Officer — President · Director
Period of report
Sep 15, 2015
Accepted (ET)
Sep 16, 2015 · 6:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000910267
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 15, 2015 | P | 5,000 | $0.69 | A | 486,500 | D | |
| Common Stock | Sep 16, 2015 | P | 5,000 | $0.70 | A | 491,500 | D | |
| Common StockF1 | holding | — | — | — | 300,757 | I | By Family Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person serves as trustee of the family trust.